{"classes":[{"categories":[{"measurements":[{"comment":"Here 'NA' represents that upper limit of 95% CI was not estimable due to lesser number of events.","groupId":"OG000","lowerLimit":"33.15","upperLimit":"NA","value":"47.41"},{"groupId":"OG001","lowerLimit":"11.07","upperLimit":"23.95","value":"16.62"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"597"},{"groupId":"OG001","value":"602"}],"units":"Participants"}],"description":"Time to pain progression was defined as the time (in months) interval from randomization to the first date a participant experienced a greater than or equal to (\\>=) 30 percent (%) increase in Brief Pain Inventory-Short Form (BPI-SF) from baseline in the BPI-SF worst pain intensity (Item 3) observed at 2 consecutive evaluations (\\>=4) weeks apart. BPI-SF was an 11-item questionnaire, designed to assess severity and impact of pain on daily functions. Total score ranged from 0 to 10 with 0 representing \"no pain\" and 10 representing\" pain as bad as you can imagine.","dispersionType":"95% Confidence Interval","groups":[{"description":"Participants received abiraterone acetate tablet at a total dose of 1000 milligram (mg) plus 5 mg capsule of prednisone orally once daily until disease progression, withdrawal of consent or unacceptable toxicity. Stable regimen of androgen deprivation therapy (ADT) was administered.","id":"OG000","title":"Abiraterone Acetate+Prednisone+ADT"},{"description":"Participants received placebo matched to abiraterone acetate plus prednisone orally once daily until disease progression, withdrawal of consent or unacceptable toxicity. Stable regimen of ADT was administered.","id":"OG001","title":"Placebo + ADT"}],"paramType":"MEDIAN","populationDescription":"ITT analysis set included all subjects randomized into the study and who were classified according to their assigned treatment group, regardless of the actual treatment received.","reportingStatus":"POSTED","timeFrame":"Up to 66 months","title":"Time to Pain Progression","type":"SECONDARY","unitOfMeasure":"Months"}